Remove Construction Remove Court Remove Legal Remove Prima Facie Case
article thumbnail

Proper analysis for petition to dismiss under Tennessee Public Participation Act (TPPA).

Day on Torts

Rock Creek Construction, Inc. , 1, 2022), plaintiffs filed suit against defendant construction company related to defendant’s construction of plaintiffs’ residential home, and defendant filed a counterclaim, which was the claim at issue in this appeal. The Court of Appeals quoted Tenn. In Reiss v. quoting Tenn.

article thumbnail

Supreme Court on Patent Law: November 2023

Patently O

by Dennis Crouch The Supreme Court is set to consider several significant patent law petitions addressing a range of issues from the application of obviousness standards, challenges to PTAB procedures, interpretation of joinder time limits IPR, to the proper scope patent eligibility doctrine. Mangrove Partners Master Fund (No. Fortinet (No.

Court 75
article thumbnail

Obviousness and Pharmaceutical Method of Treatment Claims

Patently O

by Dennis Crouch In April 2024, the Federal Circuit issued a significant decision vacating a district court’s judgment that Janssen Pharmaceuticals’ dosing regimen patent claims were nonobvious. The case involved Janson’s U.S. Overall, this is a bad case for pharmaceutical formulary patents. Janssen Pharms.,